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Objectives: The aim of this study is to analyse national trends in discharge disposition following
pancreatic resection for malignancy in the USA.
Methods: The Nationwide Inpatient Sample database was queried for 1993–2005 to identify patients
who underwent pancreatic resection for malignancy. The status of patients at discharge (to home, home
with home health care or to another facility) was noted.
Results: A weighted total of 51 866 patients who underwent pancreatectomy for malignant neoplasm of
the pancreas were identified. Patients who died in the postoperative period and patients without a
specified discharge disposition were excluded, leaving 43 603 patients for inclusion in the study. Overall
mortality improved over the period of the study from 7.1% in 1993 to 5.2% in 2005. The number of
patients discharged to another facility increased significantly from 5.5% in 1993 to 13.3% in 2005.
Similarly, the number of patients discharged to home with home health assistance increased from 20.0%
in 1993 to 33.0% in 2005. This corresponded with a statistically significant decrease in the number of
patients discharged to home without assistance, from 74.5% in 1993 to 53.7% in 2005 (P = 0.002).
Conclusions: The results of our study demonstrate that following pancreatic resection for malignancy,
nearly half the patients will require some assistance after discharge.
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Introduction
Pancreatic resection is increasingly performed in the USA for
various neoplastic lesions involving the pancreas, particularly in
elderly patients with multiple preoperative comorbidities.1,2 Sur-
gical resection is the only modality to offer any hope of prolonged
survival and 5-year survival rates range from 18% to 41% in
selected patients.3–10 Although perioperative mortality3–5 has sig-
nificantly decreased over the years, considerable morbidity is
associated with such resections.2–8
The occurrence of postoperative morbidity determines the
length of stay and the final discharge disposition. Studies of out-
comes following pancreatic resection have traditionally focused
on perioperative mortality and morbidity,2–8 such as manifested
by pancreatic fistula and delayed gastric emptying.1–4,9 We have
previously shown that, despite a declining mortality rate, the
number of patients who are discharged to home following hepatic
resection for malignancy has decreased.11 Data on discharge dis-
position trends following pancreatic resection for malignancy are
scarce. The aims of this study were to: (i) analyse national trends
in discharge disposition following pancreatic resection for malig-
nancy, and (ii) determine the factors that influence discharge
disposition.
This paper is based on a mini oral presentation given at the 11th Annual
Meeting of the American Hepato-Pancreato-Biliary Association, 10–13
March 2011, Miami, Florida.
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Materials and methods
Data source
Data drawn from the Nationwide Inpatient Sample (NIS) were
utilized to analyse trends in discharge status following pancreatic
resection for malignancy. The NIS is a database developed as
part of the Healthcare Cost and Utilization Project (HCUP),
sponsored by the Agency for Healthcare Research and Quality
(Rockville, MD, USA). The NIS is designed to approximate a 20%
sample of US community hospitals. In 2005, NIS data included
discharge data from 1054 hospitals located in 37 states.
The NIS database was queried for 1993–2005 to identify
patients discharged with International Classification of Diseases,
9th Revision, Clinical Modification (ICD-9-CM) procedure
codes for pancreatectomy [5251 (proximal pancreatectomy), 5252
(distal pancreatectomy), 5253 (radical subtotal pancreatectomy),
5259 (other partial pancreatectomy), 526 (total pancreatectomy),
527 (radical pancreatectomy)] and diagnosis codes for malignant
neoplasms of the pancreas [1570 (head of pancreas), 1571 (body
of pancreas), 1572 (tail of pancreas), 1573 (pancreatic duct), 1578
(other specified pancreas sites), 1579 (pancreas, part unspeci-
fied)]. Patients who underwent pancreatic resection for benign
conditions were excluded. Data on patient age, gender, race and
income, admission type, hospital size and type, diagnosis, pres-
ence of preoperative comorbidities, extent of resection and length
of stay were extracted from the database. Preoperative comorbid
conditions were identified using the taxonomy published by
Elixhauser et al.12
The status of patients at discharge was noted. ‘Routine’ or
‘home’ discharge was defined as discharge to the patient’s home
with no health care assistance. ‘Home health care’ discharge was
defined as discharge to the patient’s home with acknowledged
need for the assistance of a visiting nurse or other skilled health
care personnel. ‘Other facility’ discharge was defined as discharge
or transfer to a skilled nursing, subacute care or nursing facility.
For further analysis, ‘Home health care’ and ‘Other facility’
discharge were grouped within the category of ‘Non-routine’
discharge.
Statistical methods
SAS version 9.2 (SAS Institute, Inc., NC, USA) and SUDAAN
release 10.0 (Research Triangle Institute, Raleigh, NC, USA) were
used for all statistical analyses to account for the complex sam-
pling design of the NIS. Weighted sample estimates, standard
errors and 95% confidence intervals (CIs) were calculated using
the Taylor expansion method. All statistical tests were two-sided
and P-values of <0.05 were considered to indicate statistical
significance.
A Cochran–Mantel–Haenszel analysis of variance (anova)-
type test for trend was used to compare changes in discharge
status over time. Chi-squared tests were used to compare patient
characteristics by discharge status over the entire study period.
Multivariate logistic regression analysis using backwards variable
selection was conducted to find significant predictors of routine
discharge.
Results
A weighted total of 51 866 patients underwent a primary proce-
dure of pancreatectomy between 1993 and 2005 for malignant
neoplasm of the pancreas. Patients who died in the postopera-
tive period (n = 2999), patients who left against medical advice
(n = 11) and patients for whom no post-hospital disposition was
indicated (n = 5253) were excluded, leaving 43 603 patients for
inclusion in the study. Overall mortality improved from 7.1% in
1993 to 5.2% in 2005.
Trends in discharge dispositions following pancreatic resection
for malignancy are shown in Fig. 1. We noted a significant
decrease in the number of patients discharged to home without
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Figure 1 Patient discharge disposition over time after excluding mortality. ‘Other facility’ includes discharge to short-term hospitals, skilled
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Table 1 Univariate analysis showing comparisons in rates of routine and non-routine discharge by patient characteristics for 1993–2005
n Routinea, % Non-routinea, % P-value
Pancreatectomy type
Radical 31 707 58 42 <0.0001
Distal 7 016 74 26
Other 4 880 63 37
Pancreas neoplasm location
Head 27 835 58 42 <0.0001
Other 15 768 67 33
Age
70 years 26 988 70 30 <0.0001
>70 years 16 614 47 53
Sex
Male 21 560 64 36 <0.0001
Female 22 043 59 41
Admission type
Non-elective 12 551 56 44 <0.0001
Elective 29 359 64 36
Size of hospital
Small 3 224 55 45 0.064
Medium 7 754 58 42
Large 32 620 63 37
Hospital
Non-teaching 15 847 61 39 0.74
Teaching 27 751 62 38
Race
Non-White 5 575 64 36 0.12
White 27 293 60 40
Income, US$
1–24 999 6 879 58 42 0.086
25 000–34 999 11 393 62 38
35 000–44 999 10 158 63 37
45 000 12 298 60 40
Length of stay
10 days 14 646 77 23 <0.0001
>10 days 28 957 54 46
Comorbidities, n
2 40 420 62 38 <0.0001
3 3 183 50 50
Renal failure
No 43 343 62 38 0.020
Yes 260 45 55
Other neurologic disease
No 43 240 62 38 0.016
Yes 363 46 54
Hypothyroid
No 41 242 62 38 0.081
Yes 2 361 57 43
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assistance (from 74.5% to 53.7%) and a corresponding increase in
discharges to other facilities (from 5.5% to 13.3%) or to home
with home health care (from 20.0% to 33.0%) during the study
period. A total of 46.3% of patients were noted to be unfit to be
discharged home without assistance in 2005.
The univariate analysis of the influence of various variables
on discharge disposition is shown in Table 1. Significant associa-
tions were found between discharge disposition and extent of
resection, location of tumour, gender, age >70 years, preopera-
tive presence of three or more comorbidities, admission type,
size of hospital and postoperative length of stay (Table 1). We
performed multivariate logistic regression analysis to predict
the probability of a routine vs. a non-routine discharge. Several
factors were noted to have independent effects on discharge
disposition, including age, sex and number of comorbidities
(Table 2).
Age >70 years, the preoperative presence of three or more
comorbidities and length of hospital stay were noted to have the
most significant influence on discharge disposition following pan-
creatic resection for malignancy. Analysis of trends over the period
of the study revealed that the number of patients aged >70 years
with more than three preoperative comorbidities undergoing
pancreatectomy increased over time (Table 3). This increase was
more pronounced for patients with more than three preoperative
comorbidities.
The analysis of trends in discharge disposition based on
advanced age and the preoperative presence of more than three
comorbidities (Figs 2–4) demonstrated a decrease in the home
discharge rate in both groups. In patients aged >70 years, the
home discharge rate decreased from 68.8% to 36.0%. Similarly, in
patients with more than three preoperative comorbidities, the
home discharge rate decreased from 60.6% to 40.8%. The combi-
nation of advanced age and more than three preoperative comor-
bidities reduced the likelihood of home discharge even further to
34.1% in 2005.
Discussion
Currently, pancreatic resections are performed with low mortality
and acceptable morbidity rates.2–8 Despite the improvement in
perioperative mortality, only 53.7% of patients in the current
study recovered sufficiently to be discharged home without assis-
tance in 2005. These findings are similar to outcomes noted for
another major procedure, hepatic resection.11 Shah et al.11 docu-
mented that although perioperative mortality had improved,
fewer patients were discharged home after hepatic resection.
Several factors were noted to have a negative association with
discharge disposition, of which age and the preoperative presence
of more than three comorbidities were the most significant.11 In
the current study, we noted a similar association of advanced age
and the preoperative presence of more than three comorbidities
with discharge disposition (Table 1, Fig. 2).
It is clear that pancreatic resection can be performed in elderly
populations with acceptable mortality and morbidity, but fewer of
Table 1 Continued
n Routinea, % Non-routinea, % P-value
CHF
No 42 142 62 38 <0.0001
Yes 1 460 41 59
Liver disease
No 42 609 61 39 0.86
Yes 994 61 39
Hypertension
No 29 453 63 37 <0.0001
Yes 14 149 58 42
Cardiac arrhythmia
No 39 511 63 37 <0.0001
Yes 4 092 49 51
Diabetes
No 33 219 62 38 0.0043
Yes 10 384 58 42
COPD
No 39 017 62 38 <0.0001
Yes 4 586 55 45
aRoutine discharge means discharge to home without any need for assistance; non-routine discharge means discharge to home with home health care
or to a skilled nursing or rehabilitation facility.
CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease.
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these patients will be discharged home.1,2 A 10-year Italian study
of patients undergoing pancreaticoduodenectomy, conducted by
Brozzetti et al.,13 demonstrated higher postoperative mortality
in elderly patients. A recent study from the Mayo Clinic, which
included octogenarians undergoing pancreaticoduodenectomy,14
the older population (aged >80 years) included more high-risk
patients with respect to American Society of Anesthesiologists
(ASA) status, had an increased length of stay and was more likely
to develop complications. By contrast, single-institution studies
by Hatzaras et al.,1 Makary et al.15 and Sohn et al.16 have shown
that age does not influence postoperative mortality after pancre-
aticoduodenectomy and some studies have even documented
similar morbidity rates.1
Despite these contradictory findings, our study analysed
another important perioperative outcome variable to reveal that
patients aged >70 years are likely to need increased assistance
after discharge. The size of the elderly population in the USA has
increased exponentially over the last century, and the proportion
of older patients with resectable pancreatic malignancies has also
increased.17 We noticed that a greater proportion of older
Table 3 Trends in numbers of patients undergoing pancreatic
resection based on age and number of comorbidities (1993–2005)
Percentage of patients
Age, years Comorbidities
70 >70 3 2
1993 68.26 31.74 4.16 95.84
1994 64.37 35.63 6.22 93.78
1995 63.73 36.27 7.31 92.69
1996 61.35 38.65 4.90 95.10
1997 61.69 38.31 4.56 95.44
1998 57.94 42.06 5.80 94.20
1999 60.50 39.50 7.79 92.21
2000 59.61 40.39 5.66 94.34
2001 57.96 42.04 9.51 90.49
2002 64.42 35.58 8.59 91.41
2003 60.33 39.67 8.80 91.20
2004 64.52 35.48 9.88 90.12
2005 59.27 40.73 10.21 89.79
Table 2 Multivariate model showing probabilities for routine vs. non-routine dischargea, using a logistic regression model
Odds ratio 95% confidence interval P-value
Year 1993 3.46 2.16–5.54 <0.0001
1994 2.96 2.04–4.29
1995 2.16 1.41–3.33
1996 1.92 1.28–2.88
1997 2.03 1.42–2.90
1998 1.67 1.06–2.62
1999 1.92 1.34–2.76
2000 1.42 0.98–2.06
2001 1.43 0.96–2.15
2002 1.58 1.06–2.36
2003 1.36 0.94–1.95
2004 0.96 0.66–1.39
2005 Ref –
Pancreatectomy type Radical Ref – 0.014
Distal 1.33 1.10–1.61
Other 1.07 0.88–1.29
Pancreas neoplasm location Head Ref – 0.038
Other 1.16 1.01–1.33
Age group 70 years Ref – <0.0001
>70 years 0.39 0.35–0.43
Sex Male 1.24 1.12–1.37 <0.0001
Female Ref –
Admission type Non-elective 0.87 0.77–0.99 0.032
Elective Ref –
Bed size of hospital Small/medium Ref – 0.014
Large 1.29 1.05–1.58
Number of comorbidities 2 Ref – 0.0067
3 0.77 0.64–0.93
Length of stay 10 days Ref – <0.0001
>10 days 0.34 0.29–0.40
aRoutine discharge means discharge to home without any need for assistance; non-routine discharge means discharge to home with home health care
or to a skilled nursing or rehabilitation facility.
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patients are now undergoing pancreatic resection (Table 3),
which may lead to a greater number of patients requiring assis-
tance upon discharge. As the number of people over 70 years of
age increases in the USA, more patients will be likely to require
assistance in the future. This implies an increase in the costs of
health care overall and in individual needs for nursing and home
health care resources.
Patient-related factors, such as the presence of preoperative
comorbidities, have been suggested to represent significant fac-
tors contributing towards higher complication rates in elderly
patients.18–22 Adam et al.21 noted that certain preoperative
comorbidities, such as impaired renal function, had an adverse
influence on postoperative morbidity. In another study analysing
the influence of hospital volume on postoperative morbidity,22
serum creatinine levels and need for blood transfusion were found
to be independent risk factors for complications after pancreati-
coduodenectomy. The current study demonstrates that we now
operate on more patients with three or more preoperative comor-
bidities (Table 2, Figs 2, 4) and that these patients are less likely to
be discharged home compared with patients with fewer than three
preoperative comorbidities.
We did not find an independent association between diabetes
mellitus and final discharge disposition. In a related prospective
study, Chu et al.23 analysed the influence of diabetes on various
perioperative outcome variables. Although diabetes increased the
risk for pancreatic fistula and acute kidney injury, it had no influ-
ence on several other variables, such as delayed gastric emptying,
wound infections, intra-abdominal abscesses, cardiovascular and
90
80
70
60
50
40
30
20
10
0
R
ou
tin
e 
di
sc
ha
rg
e,
 %
≤ 70 years
> 70 years
1993
77.11
68.83
77.74
55.54
71.76
49.23
72.27
44.81
70.76
52.92
69.97
49.39
73.12
47.79
70.57
40.70
67.18
44.37
69.79
48.12
66.92
44.46
63.47
37.90
65.57
36.44
1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
Figure 2 Percentage of patients given routine (home) discharge based on age
80
70
60
50
40
30
20
10
0
R
ou
tin
e 
di
sc
ha
rg
e,
 %
≥ 3 comorbidities
≤ 2 comorbidities
1993
60.62
75.09
55.69
70.77
53.74
64.37
56.90
61.90
54.50
64.38
59.46
61.42
60.57
63.33
48.32
59.12
44.11
59.01
47.73
63.43
51.58
58.63
45.17
55.41
40.82
55.17
1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
Figure 3 Percentage of patients given routine (home) discharge by number of comorbidities
206 HPB
HPB 2012, 14, 201–208 © 2012 International Hepato-Pancreato-Biliary Association
pulmonary complications, length of stay and mortality.23 A sur-
prising finding in our study is the negative influence of female
gender on discharge disposition, although the perioperative mor-
tality rate in female patients is lower than that in male patients.9
The reasons for these dichotomous outcomes are not clear and the
issues warrant further study.
There are several limitations to this study. The NIS database
does not provide for detailed analysis of postoperative morbidity.
The type and severity of postoperative complications can have
significant bearing on discharge disposition and analysis of post-
operative complications would help in identifying the subgroup of
patients who are less likely to be routinely discharged. The present
system of health care in the USA encourages an emphasis on
discharging patients as soon as possible from an acute care setting.
However, because the NIS database does not contain information
on postoperative morbidity, we were unable to further analyse this
type of correlation.
The NIS database does not contain information on the extent of
resection or the administration of chemotherapy. In the last few
decades, extended resections of segments of portal and mesenteric
vessels have been performed in attempts to achieve curative
resection.24–29 Despite increasing operative morbidity, this aggres-
sive approach has led to a wider recruitment of patients for poten-
tially curative surgery. However, the fact that the patient
population undergoing extended pancreatic resection is becoming
increasingly elderly, with a higher number of preoperative comor-
bidities, (Fig. 4), and a lower physiologic reserve, is likely to influ-
ence discharge disposition in the future. Reports on preoperative
chemoradiation are contradictory24 and very little is known about
its effects on postoperative morbidity, length of stay and thus
discharge disposition. The fact that information on extended
resections and administration of chemotherapy is lacking should
be kept in mind when interpreting the results of this study.
The NIS database does not account for individual surgeon or
institution policy, such as the incorporation of critical care path-
ways on discharge status. Similarly, the NIS database does not
include clear data on the type of surgical approach (open, laparo-
scopic or robotic) taken to pancreatic resection. It is known
that the type of surgical approach may influence perioperative
outcomes and thereby affect discharge disposition.30
In summary, the results of this study demonstrate that,
following pancreatic resection for malignancy, nearly 50% of
patients will need some assistance upon discharge. Patients aged
>70 years and those with three or more preoperative comorbidi-
ties are more likely to need assistance after discharge. This infor-
mation should be borne in mind during risk stratification and
patient counselling prior to operative intervention for pancreatic
malignancy.
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